BioSig Technologies (BSGM) Stock Price, News & Analysis

Company Overview

BioSig Technologies, Inc., together with its subsidiaries, a medical device company, engages in development and commercialization of advanced digital signal processing technology platform for the treatment of cardiovascular arrhythmias in the United States. It offers PURE EP system, a signal processing platform that combines hardware and software to address known challenges associated to signal acquisition that enables electrophysiologists to see signals and analyze in real-time, as well as is designed to address long-standing limitations that slow and disrupt cardiac catheter ablation procedures. The company has a research agreement with Mayo Foundation to develop an AI- and machine learning-powered software for PURE EP system. BioSig Technologies, Inc. was incorporated in 2009 and is headquartered in Westport, Connecticut.

Key Stats

• Today's Range: $0.31 to $0.44
• 50-Day Range: $0.34 to $0.52
• 52-Week Range: $0.20 to $6.89
• Volume: 214,995 shs
• Average Volume: 496,432 shs
• Market Capitalization: $4.36 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

BSGM Stock Analysis - Frequently Asked Questions

How have BSGM shares performed this year?

BioSig Technologies' stock was trading at $4.75 at the start of the year. Since then, BSGM shares have decreased by 93.5% and is now trading at $0.3076.
View the best growth stocks for 2024 here.

How were BioSig Technologies' earnings last quarter?

BioSig Technologies, Inc. (NASDAQ:BSGM) released its quarterly earnings data on Wednesday, August, 14th. The company reported ($0.30) earnings per share for the quarter. The firm had revenue of $0.01 million for the quarter.

When did BioSig Technologies' stock split?

BioSig Technologies shares reverse split before market open on Friday, February 2nd 2024. The 1-10 reverse split was announced on Friday, February 2nd 2024. The number of shares owned by shareholders was adjusted after the market closes on Friday, February 2nd 2024. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.

How do I buy shares of BioSig Technologies?

Shares of BSGM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

What other stocks do shareholders of BioSig Technologies own?

Based on aggregate information from My MarketBeat watchlists, some other companies that BioSig Technologies investors own include Gilead Sciences (GILD), Inovio Pharmaceuticals (INO), Pfizer (PFE), Roku (ROKU), Advanced Micro Devices (AMD), Amarin (AMRN) and Dynavax Technologies (DVAX).

Company Calendar

• Last Earnings: 8/14/2024
• Today: 9/17/2024
• Fiscal Year End: 12/31/2024

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Electromedical equipment
• Sub-Industry: Medical Equipment
• Current Symbol: NASDAQ:BSGM
• CUSIP: N/A
• CIK: 1530766
• Web: www.biosig.com
• Phone: (230) 409-5444
• Fax: N/A
• Employees: 50
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $-29,040,000.00
• Net Margins: -44,832.50%
• Pretax Margin: -43,760.00%
• Return on Equity: N/A
• Return on Assets: -746.77%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 0.80
• Quick Ratio: 0.80

Sales & Book Value

• Annual Sales: $27,000.00
• Price / Sales: 161.62
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: ($0.33) per share
• Price / Book: -0.93

Miscellaneous

• Outstanding Shares: 14,186,000
• Free Float: 12,867,000
• Market Cap: $4.36 million
• Optionable: Optionable
• Beta: 0.65